Related Experiment Video
Updated: May 13, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
An update on hybrid drugs in cardiovascular drug research
1Università di Pisa, Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, Via Bonanno 6, I-56126 Pisa - Italy +39 050 2219589 ; +39 050 2219609 ; calderone@farm.unipi.it.
Background:
Several different strategies are commonly used in medicinal chemistry to develop new molecules targeted at improving the current pharmacotherapy of cardiovascular diseases and hypertension. Among these, in the past years, we could observe an increasing development of new hybrid compounds in which two or more mechanisms of action are combined together to give a new pharmacological entity targeting, simultaneously, several factors involved in complex cardiovascular diseases.
Objective:
The aim of this review is to present the rational pharmacological bases and the chemical approaches used for the development of representative hybrid drugs.
Conclusions:
In this paper, some promising multi-targeted enzyme inhibitors and dual receptor antagonists are reported. Some examples of pharmacodynamic hybrids compounds, in which a suitable nitric oxide releasing functionality has been added to known cardiovascular drugs, are also shown.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents
Heart Failure V: Medical Management
Pharmacogenomics: Identification of New Drug Targets
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
